Ms Vanessa van Coppenhagen

Vanessa van Coppenhagen

Updates

Healthcare & Life Sciences

Life sciences acquisitions and divestments
South Africa | 01 July 2020

To establish a portfolio of investments, BioVentures, South Africa's first niche biotechnology and life sciences venture capital fund, looked for South African start-ups with proprietary technology that gives them a competitive advantage; a large, growing and preferably international market; multiple products and markets rather than a single product and market; and a quality and balanced management team. This article considers these points in more detail to create a checklist for divestiture preparation or asset hunting.